Skip to main content
. 2022 Sep 6;13(11):3280–3296. doi: 10.7150/jca.74829

Figure 5.

Figure 5

Plot of the surface under the cumulative ranking curves (SUCRA) for A, Clinical effectiveness rate; B, Quality of Life. Note: KLTI: Kanglaite injection; ADI: Aidi injection; FFBMJN: Fufang Banmao Jiaonang; PXP: Pingxiao Pian; KAI:Kangai injection; CKSI: compound kushen injection; SQFZI: Shenqifuzheng injection; LKP: Longkui Pian; SMI: Shenmai injection; XZYGP: Xiaozheng Yigan Pian; XHJN: Xihuang Jiaonang; Huaier: Huaier granule; Sor: sorafenib; ST: systemic therapy.